The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
Open accessAbstract
Without new blood vessels, neoplasms cannot expand beyond a few millimeters, the point at which the diffusion of nutrients and the disposal of waste products become rate-limiting. Regulation of angiogenesis thus must be controlled at multiple levels. For instance, the VEGF family of heparin-binding proteins and their primary receptors, VEGFR-1 and VEGFR-2 (KDR), products of the flt-1 and the flk-1 gene, respectively, are required for angioblast differentiation and vasculogenesis, and specific VEGF isoforms play distinct roles in promoting endothelial growth and migration during angiogenesis. In addition, angiogenesis is profoundly affected by several members of the FGF family and their four receptors, and indeed, supplementing the media of endothelial cell cultures with basic FGF (FGF2) and heparin is now well established as a means to obtain optimal growth, migration, and capillary morphogenesis. In addition to producing proangiogenic factors, tumor cells also directly or indirectly generate negative angiogenic stimuli. The ultimate growth rate of the tumors is thus a fine balance between positive and negative angiogenic cues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
Iozzo, R. V. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.609 · Cited by 1,637
Self-citationBrodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Specificities of heparan sulphate proteoglycans in developmental processes
Perrimon, N., & Bernfield, M. (2000) · Nature · doi:10.1038/35008000 · Cited by 714
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., & Blundell, T. L. (2000) · Nature · doi:10.1038/35039551 · Cited by 704
Whitelock, J. M., Murdoch, A. D., Iozzo, R. V., & Underwood, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10079 · Cited by 597
Self-citationNugent, M. A., & Iozzo, R. V. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00123-5 · Cited by 547
Self-citationAviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G., & Yayon, A. (1994) · Cell · doi:10.1016/0092-8674(94)90031-0 · Cited by 536
Interaction of endostatin with integrins implicated in angiogenesis
Rehn, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031564998 · Cited by 460
Yamaguchi, N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4414 · Cited by 444
Iozzo, R. V., Cohen, I. R., Grässel, S., & Murdoch, A. D. (1994) · Biochemical Journal · doi:10.1042/bj3020625 · Cited by 382
Self-citationBaeg, G.-H., Lin, X., Khare, N., Baumgartner, S., & Perrimon, N. (2001) · Development · doi:10.1242/dev.128.1.87 · Cited by 371
Kim, Y. M., Jang, J.-W., Lee, O., Yeon, J.-H., Choi, E.-Y., Kim, K., Lee, S., & Kwon, Y. (2000) · PubMed · Cited by 347
Cell Surface Glypicans Are Low-Affinity Endostatin Receptors
Karumanchi, S. A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chan, B., Dhanabal, M., Hanai, J.-I., Venkataraman, G., Shriver, Z., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00225-8 · Cited by 309
Still More Complexity in Mammalian Basement Membranes
Erickson, A. C., & Couchman, J. R. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004801001 · Cited by 303
The Elusive Functions of Proteoglycans
Lander, A. D., & Selleck, S. B. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.2.227 · Cited by 260
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer
Czubayko, F., Liaudet-Coopman, E. D. E., Aigner, A., Tuveson, A. T., Berchem, G. J., & Wellstein, A. (1997) · Nature Medicine · doi:10.1038/nm1097-1137 · Cited by 237
Yu, W.-H., & Woessner, J. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4183 · Cited by 231
Sasaki, T., Larsson, H., Tisi, D., Claesson-Welsh, L., Hohenester, E., & Timpl, R. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3996 · Cited by 220
Sasaki, T., Larsson, H., Kreuger, J., Salmivirta, M., Claesson-Welsh, L., Lindahl, U., Hohenester, E., & Timpl, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6240 · Cited by 211
Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
Sharma, B., Handler, M., Eichstetter, I., Whitelock, J. M., Nugent, M. A., & Iozzo, R. V. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3793 · Cited by 194
Self-citationDevelopmental expression of perlecan during murine embryogenesis
Handler, M., Yurchenco, P. D., & Iozzo, R. V. (1997) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199710)210:2<130::aid-aja6>3.0.co;2-h · Cited by 194
Self-citationGlypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165
Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G., & Ron, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10816 · Cited by 182
Potentiation and Inhibition of bFGF Binding by Heparin: A Model for Regulation of Cellular Response
Fannon, M. W., Forsten, K. E., & Nugent, M. A. (2000) · Biochemistry · doi:10.1021/bi991895z · Cited by 166
(2000) · CRC Press eBooks · doi:10.1201/9780203909720 · Cited by 163
The Protein Core of the Proteoglycan Perlecan Binds Specifically to Fibroblast Growth Factor-7
Mongiat, M., Taylor, K., Otto, J., Aho, S., Uitto, J., Whitelock, J. M., & Iozzo, R. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7095 · Cited by 155
Self-citationWu, D. Q., Kan, M. K., SATO, G. H., Okamoto, T., & Sato, J. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55368-0 · Cited by 151
Clasper, S., Vekemans, S., Fiore, M. M., Plebanski, M., Wordsworth, B. P., David, G., & Jackson, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24113 · Cited by 145
Göhring, W., Sasaki, T., Heldin, C., & Timpl, R. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2550060.x · Cited by 142
Jones, M., Tussey, L., Athanasou, N. A., & Jackson, D. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7964 · Cited by 131
Fibroblast Growth Factor-binding Protein Is a Novel Partner for Perlecan Protein Core
Mongiat, M., Otto, J., Oldershaw, R. A., Ferrer, F., Sato, J. D., & Iozzo, R. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011493200 · Cited by 128
Self-citationCollagen XVIII/Endostatin Structure and Functional Role in Angiogenesis.
Zätterström, U. K., Felbor, U., Fukai, N., & Olsen, B. R. (2000) · Cell Structure and Function · doi:10.1247/csf.25.97 · Cited by 117
Li, D., Clark, C. C., & Myers, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000519200 · Cited by 116
Bonneh‐Barkay, D., Shlissel, M., Berman, B., Shaoul, E., Admon, A., Vlodavsky, I., Carey, D. J., Asundi, V. K., Reich‐Slotky, R., & Ron, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12415 · Cited by 113
Aviezer, D., Iozzo, R. V., Noonan, D. M., & Yayon, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1938 · Cited by 109
Self-citation[11] Regulation by heparan sulfate in fibroblast growth factor signaling
Rapraeger, A. C., Guimond, S. E., Krufka, A., & Olwin, B. B. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)45013-7 · Cited by 105
Neumann, F. R., Bittcher, G., Annies, M., Schumacher, B., Kröger, S., & Rüegg, M. A. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0932 · Cited by 104
A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells.
Mathiak, M., Yenisey, Ç., Grant, D. S., Sharma, B., & Iozzo, R. V. (1997) · PubMed · Cited by 84
Self-citationTranscriptional Silencing of Perlecan Gene Expression by Interferon-γ
Sharma, B., & Iozzo, R. V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4642 · Cited by 67
Self-citationSuppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA
Adatia, R., Albini, A., Carlone, S., Giunciuglio, D., Benelli, R., Santi, L., & Noonan, D. M. (1997) · Annals of Oncology · doi:10.1023/a:1008243115385 · Cited by 64
Padera, R. F., Venkataraman, G., Berry, D., Godavarti, R., & Sasisekharan, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1677 · Cited by 57
Chang, Z., Choon, A., & Friedl, A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65101-2 · Cited by 56
Heparan Sulfate Proteoglycans in Basement Membranes: Perlecan, Agrin, and Collagen XVIII
Dunlevy, J. R., & Hassell, J. R. (2000) · doi:10.1201/9780203909720-16 · Cited by 5
Cited by
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
Self-citationFibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
The Structure of Glycosaminoglycans and their Interactions with Proteins
Gandhi, N. S., & Mancera, R. L. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00741.x · Cited by 1,034
Structure and function of the skeletal muscle extracellular matrix
Gillies, A. R., & Lieber, R. L. (2011) · Muscle & Nerve · doi:10.1002/mus.22094 · Cited by 1,021
Metadata
- Authors
- Iozzo, R. V., & San Antonio, J. D.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-08-01
- Volume
- 108
- Issue
- 3
- Pages
- 349-355
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2029176649
- Cited by
- 455
- References
- 44
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.